Eight patients with chronic myeloid leukemia in blast crisis were treated with a combination of vindesine and prednisone. Complete remission was achieved in three patients; partial remission was achieved in three. All six responders received maintenance treatment with hydroxyurea and 6-mercaptopurine. The median duration of survival was 9 months. Two patients had long-term survival: one survived 32 months and the other is alive after 30 months. These data suggest that vindesine-prednisone polychemotherapy might improve the prognosis of blast crisis in chronic myeloid leukemia.

Download full-text PDF

Source

Publication Analysis

Top Keywords

blast crisis
12
chronic myeloid
12
myeloid leukemia
12
crisis chronic
8
remission achieved
8
achieved three
8
vindesine-prednisone treatment
4
treatment blast
4
leukemia patients
4
patients chronic
4

Similar Publications

When Simple Orthopedic Cases Become Complex: Case Presentations From Gaza.

Cureus

December 2024

Department of Orthopedics, Jordanain Royal Medical Services, Amman, JOR.

Orthopedic injuries in Gaza, many of which would be straightforward to manage under normal circumstances, have become increasingly complex and challenging due to ongoing conflict, severe healthcare limitations, and delayed treatment. This review highlights cases of injuries that, if treated promptly, could have been managed with standard protocols but have evolved into complicated and difficult-to-treat conditions. Delayed care, lack of resources, and restricted rehabilitation significantly increase the complexity of treatment and lead to higher rates of complications, and impaired outcomes.

View Article and Find Full Text PDF

Long non-coding RNAs (lncRNAs) and RNA N6-methyladenosine (mA) have been linked to leukemia drug resistance. However, whether and how lncRNAs and mA coordinately regulate resistance remain elusive. Here, we show that many differentially expressed lncRNAs enrich mA, and more lncRNAs tend to have higher mA content in CML cells resistant to tyrosine kinase inhibitors (TKIs).

View Article and Find Full Text PDF

Chronic myeloid leukemia (CML) typically progresses from a chronic phase to an accelerated phase, and eventually to a blast crisis, often involving the bone marrow and peripheral blood, if left untreated. Central nervous system (CNS) involvement is an uncommon manifestation of CML, particularly as an isolated CNS relapse. Here, we present a rare case of CML in lymphoid blast crisis with an isolated CNS relapse.

View Article and Find Full Text PDF
Article Synopsis
  • Polymyositis is a rare complication of graft-versus-host disease (GvHD) that primarily affects muscle tissues, particularly in patients after stem cell transplants.
  • A 23-year-old male with chronic myeloid leukemia experienced severe muscle weakness and respiratory issues six months post-transplant, leading to the diagnosis of GvHD polymyositis through various tests including muscle biopsies and imaging.
  • The patient responded positively to treatments like corticosteroids and extracorporeal photopheresis, underscoring the need for prompt diagnosis and a collaborative approach to managing this condition.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!